Revvity, INC. (RVTY) SEC Filings — 2024
22 SEC filings for Revvity, INC. (RVTY) in 2024.
Filings
- Revvity, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Revvity, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Revvity, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Revvity, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Revvity, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Revvity, Inc. Q3 2024 10-Q Filing — 10-Q · Nov 6, 2024
- Revvity, Inc. Files 8-K on Financials — 8-K · Nov 4, 2024
- Revvity Reports Q2 2024 Results — 10-Q · Aug 6, 2024
- Revvity, Inc. Files 8-K on Financials — 8-K · Jul 29, 2024
- Revvity, Inc. Files 10-Q for Q1 2024 — 10-Q · May 7, 2024
- Revvity Sells Applied Genomics for ~$1B — 8-K · Apr 29, 2024
- Revvity, Inc. Reports on Shareholder Vote Matters — 8-K · Apr 24, 2024
- Revvity, Inc. Schedules 2024 Annual Meeting of Shareholders — DEF 14A · Mar 13, 2024
- Revvity, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 27, 2024
- Revvity, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Revvity, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Revvity, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Capital Research Global Investors Amends Revvity Stake — SC 13G/A · Feb 9, 2024
- Revvity 8-K Confirms Financial Condition, 1.875% Notes Due 2026 — 8-K · Feb 1, 2024
- Revvity 8-K Signals Potential Leadership/Comp Changes — 8-K · Jan 26, 2024
- BlackRock Amends Revvity Stake to 12.0% as of Dec 31, 2023 — SC 13G/A · Jan 26, 2024
- Revvity to Present at J.P. Morgan Healthcare Conference — 8-K · Jan 9, 2024